Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)

BACKGROUND: Small cell lung cancer (SCLC) accounts for 10–15% of all lung malignancies and its prognosis is dismal. Although early studies have shown promising clinical activity of immune checkpoint blockers, the immune composition and expression of potentially actionable immunostimulatory targets i...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvajal-Hausdorf, Daniel, Altan, Mehmet, Velcheti, Vamsidhar, Gettinger, Scott N., Herbst, Roy S., Rimm, David L., Schalper, Kurt A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408760/
https://www.ncbi.nlm.nih.gov/pubmed/30850021
http://dx.doi.org/10.1186/s40425-019-0540-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408760/
https://www.ncbi.nlm.nih.gov/pubmed/30850021
http://dx.doi.org/10.1186/s40425-019-0540-1

Ejemplares similares